BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10342736)

  • 1. Impact of Flt-3 ligand on donor-derived antigen presenting cells and alloimmune reactivity in heart graft recipients given adjuvant donor bone marrow.
    Khanna A; Antonysamy MA; Subbotin VM; Steptoe RJ; Li W; Rudert WA; Thomson AW
    Transpl Immunol; 1998 Dec; 6(4):225-34. PubMed ID: 10342736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus.
    Morelli AE; Antonysamy MA; Takayama T; Hackstein H; Chen Z; Qian S; Zurowski NB; Thomson AW
    J Immunol; 2000 Jul; 165(1):226-37. PubMed ID: 10861056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flt-3 ligand increases microchimerism but can prevent the therapeutic effect of donor bone marrow in transiently immunosuppressed cardiac allograft recipients.
    Antonysamy MA; Steptoe RJ; Khanna A; Rudert WA; Subbotin VM; Thomson AW
    J Immunol; 1998 Apr; 160(8):4106-13. PubMed ID: 9558122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow.
    Khanna A; Steptoe RJ; Antonysamy MA; Li W; Thomson AW
    Transplantation; 1998 Feb; 65(4):479-85. PubMed ID: 9500620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by FLT3 ligand and tacrolimus.
    Iyengar AR; Bonham CA; Antonysamy MA; Subbotin VM; Khanna A; Murase N; Rao AS; Starzl TE; Thomson AW
    Transplantation; 1997 May; 63(9):1193-9. PubMed ID: 9158008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
    Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
    Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential induction of Th1 responses by functionally mature hepatic (CD8alpha- and CD8alpha+) dendritic cells: association with conversion from liver transplant tolerance to acute rejection.
    Morelli AE; O'Connell PJ; Khanna A; Logar AJ; Lu L; Thomson AW
    Transplantation; 2000 Jun; 69(12):2647-57. PubMed ID: 10910289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trafficking of APC from liver allografts of Flt3L-treated donors: augmentation of potent allostimulatory cells in recipient lymphoid tissue is associated with a switch from tolerance to rejection.
    Steptoe RJ; Li W; Fu F; O'Connell PJ; Thomson AW
    Transpl Immunol; 1999 Mar; 7(1):51-7. PubMed ID: 10375078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients.
    Fu F; Li Y; Qian S; Lu L; Chambers F; Starzl TE; Fung JJ; Thomson AW
    Transplantation; 1996 Sep; 62(5):659-65. PubMed ID: 8830833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity.
    Qian S; Lu L; Fu F; Li W; Pan F; Steptoe RJ; Chambers FG; Starzl TE; Fung JJ; Thomson AW
    Transplantation; 1998 Jun; 65(12):1590-8. PubMed ID: 9665075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal donor bone marrow is superior to Flt3 ligand-mobilized bone marrow in prolonging heart allograft survival when combined with anti-CD40L (CD154).
    Hackstein H; Wang Z; Morelli AE; Kaneko K; Takayama T; Colvin BL; Bein G; Thomson AW
    Am J Transplant; 2002 Aug; 2(7):609-17. PubMed ID: 12201361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroviral delivery of transforming growth factor-beta1 to myeloid dendritic cells: inhibition of T-cell priming ability and influence on allograft survival.
    Takayama T; Kaneko K; Morelli AE; Li W; Tahara H; Thomson AW
    Transplantation; 2002 Jul; 74(1):112-9. PubMed ID: 12134108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors.
    Antonysamy MA; Fanslow WC; Fu F; Li W; Qian S; Troutt AB; Thomson AW
    J Immunol; 1999 Jan; 162(1):577-84. PubMed ID: 9886435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of donor-derived dendritic cell progenitors in bone marrow of spontaneously tolerant liver allograft recipients.
    Thomson AW; Lu L; Wan Y; Qian S; Larsen CP; Starzl TE
    Transplantation; 1995 Dec; 60(12):1555-9. PubMed ID: 8545889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells.
    Garrovillo M; Ali A; Oluwole SF
    Transplantation; 1999 Dec; 68(12):1827-34. PubMed ID: 10628758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver-derived dendritic cells induce donor-specific hyporesponsiveness: use of sponge implant as a cell transplant model.
    Chiang YJ; Lu L; Fung JJ; Qian S
    Cell Transplant; 2001; 10(3):343-50. PubMed ID: 11437079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor.
    Lu L; Rudert WA; Qian S; McCaslin D; Fu F; Rao AS; Trucco M; Fung JJ; Starzl TE; Thomson AW
    J Exp Med; 1995 Aug; 182(2):379-87. PubMed ID: 7629500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting effects of myeloid dendritic cells transduced with an adenoviral vector encoding interleukin-10 on organ allograft and tumour rejection.
    Lee WC; Qiani S; Wan Y; Li W; Xing Z; Gauldie J; Fung JJ; Thomson AW; Lu L
    Immunology; 2000 Oct; 101(2):233-41. PubMed ID: 11012777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotype, function, and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-beta.
    Lee WC; Zhong C; Qian S; Wan Y; Gauldie J; Mi Z; Robbins PD; Thomson AW; Lu L
    Transplantation; 1998 Dec; 66(12):1810-7. PubMed ID: 9884280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.